BioNTech SE (BNTX)

Company Profile

BioNTech SE is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases.

Company profile

Ticker

BNTX

Exchange

NASDAQ

Website

biontech.de

CEO

Ugur Sahin

Incorporated

Germany

Location

Germany

Fiscal year end

Dec 31

Sector

Manufacturing > Biological Product (except Diagnostic) Manufacturing

Industry (SIC)

Biological Products, (No Diagnostic Substances)

AMGEN • Gilead Sciences • Biogen • Qiagen • Moderna • Sana Biotechnology • Bio-Techne • Exelixis • Ginkgo Bioworks • Acorda Therapeutics ...

SEC CIK

0001776985

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

BNTX stock data

1M 1Y 5Y

Analyst ratings and price targets

Last 3 months

Average target

$181.00

Low target

$142.00

High target

$216.00

Latest filings (excl ownership)

View all

6-K

BioNTech Announces New ADS Repurchase Program

28 Mar 23

20-F

2022 FY

Annual report (foreign)

27 Mar 23

6-K

BioNTech Announces Fourth Quarter and Full Year 2022 Financial Results and Corporate Update

27 Mar 23

6-K

BioNTech and OncoC4 Announce Strategic Collaboration to Co-Develop and Commercialize Novel Checkpoint Antibody in Multiple Solid Tumor Indications

20 Mar 23

6-K

Pfizer and BioNTech Receive U.S. Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Booster

14 Mar 23

6-K

Current report (foreign)

1 Mar 23

6-K

Current report (foreign)

24 Feb 23

S-8

Registration of securities for employees

13 Feb 23

S-8 POS

Registration of securities for employees (post-effective amendment)

13 Feb 23

6-K

Current report (foreign)

10 Jan 23

Transcripts

View all

BNTX

Earnings call transcript

2022 Q4

27 Mar 23

BNTX

Earnings call transcript

2022 Q1

9 May 22

BNTX

Earnings call transcript

2021 Q4

30 Mar 22

BNTX

Earnings call transcript

2021 Q3

9 Nov 21

BNTX

Earnings call transcript

2021 Q2

9 Aug 21

BNTX

Earnings call transcript

2021 Q1

10 May 21

BNTX

Earnings call transcript

2020 Q4

30 Mar 21

BNTX

Earnings call transcript

2020 Q3

11 Nov 20

Latest ownership filings

View all

Beneficial ownership report

12 Feb 20

Financial summary

Financial statements Chart BNTX financial data

Quarter (USD)	Dec 22	Dec 21	Dec 20	Dec 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 22	Dec 21	Dec 20	Dec 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from BioNTech SE earnings reports.

Institutional ownership, Q4 2022

BNTX institutional ownership history Ownership history

77.0% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	315	261	+20.7%
Opened positions	76	23	+230.4%
Closed positions	22	55	-60.0%
Increased positions	100	72	+38.9%
Reduced positions	82	99	-17.2%

13F shares	Current	Prev Q	Change
Total value	5.91 tn	32.40 bn	+18128.2%
Total shares	187.39 mm	185.32 mm	+1.1%
Total puts	2.01 mm	1.92 mm	+4.5%
Total calls	1.68 mm	1.60 mm	+5.0%
Total put/call ratio	1.2	1.2	-0.5%

Largest owners	Shares	Value	Change
Athos KG	105.61 mm	$0.00	-0.5%
Medine GmbH	41.41 mm	$0.00	-0.2%
Baillie Gifford & Co	7.72 mm	$1.16 tn	+6.5%
Temasek	4.38 mm	$657.67 bn	0.0%
Primecap Management	4.17 mm	$626.89 bn	-0.5%
Flossbach Von Storch	3.28 mm	$493.13 bn	-2.4%
Artisan Partners Limited Partnership	2.41 mm	$361.53 bn	+8.0%
Capital World Investors	2.07 mm	$310.71 bn	+27.3%
BLK Blackrock	2.06 mm	$309.23 bn	+36.1%
T. Rowe Price	784.28 k	$118.16 bn	-37.6%

Largest transactions	Shares	Bought/sold	Change
FOSUF Fosun International	0.00	-761.54 k	EXIT
BLK Blackrock	2.06 mm	+545.62 k	+36.1%
Athos KG	105.61 mm	-501.76 k	-0.5%
Pictet Asset Management	109.03 k	-476.10 k	-81.4%
Baillie Gifford & Co	7.72 mm	+473.05 k	+6.5%
T. Rowe Price	784.28 k	-472.03 k	-37.6%
Capital World Investors	2.07 mm	+443.59 k	+27.3%
Renaissance Technologies	331.48 k	+331.48 k	NEW
Twin Tree Management	50.84 k	-250.58 k	-83.1%
Marshall Wace	382.40 k	+237.71 k	+164.3%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.